Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Indobufen Tablets

Approval Number

国药准字H20244933

Company山东鲁盛制药有限公司

Registration Date

September 19, 2024

Drug Information

Generic Name

吲哚布芬片

Dosage Form

片剂

Strength

0.2g

Drug Type

化学药品

Registration Date

September 19, 2024

Company Information

Applicant Company

Company Name山东鲁盛制药有限公司

Company Address

山东省德州市经济技术开发区宋官屯街道办事处瑞康大道499号

Manufacturing Company

Company Name山东鲁盛制药有限公司

Company Address

山东省德州市经济技术开发区宋官屯街道办事处瑞康大道499号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

吲哚布芬片 - NMPA 批准文号 | MedPath